531 related articles for article (PubMed ID: 25194056)
1. Pegylated bisacycloxypropylcysteine, a diacylated lipopeptide ligand of TLR6, plays a host-protective role against experimental Leishmania major infection.
Pandey SP; Chandel HS; Srivastava S; Selvaraj S; Jha MK; Shukla D; Ebensen T; Guzman CA; Saha B
J Immunol; 2014 Oct; 193(7):3632-43. PubMed ID: 25194056
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of CD40-induced N-Ras activation reduces leishmania major infection.
Chakraborty S; Srivastava A; Jha MK; Nair A; Pandey SP; Srivastava N; Kumari S; Singh S; Krishnasastry MV; Saha B
J Immunol; 2015 Apr; 194(8):3852-60. PubMed ID: 25786685
[TBL] [Abstract][Full Text] [Related]
3. TLR9-deficiency reduces TLR1, TLR2 and TLR3 expressions in Leishmania major-infected macrophages.
Pandey SP; Doyen N; Mishra GC; Saha B; Chandel HS
Exp Parasitol; 2015 Jul; 154():82-6. PubMed ID: 25911242
[TBL] [Abstract][Full Text] [Related]
4. Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer.
Kang JY; Nan X; Jin MS; Youn SJ; Ryu YH; Mah S; Han SH; Lee H; Paik SG; Lee JO
Immunity; 2009 Dec; 31(6):873-84. PubMed ID: 19931471
[TBL] [Abstract][Full Text] [Related]
5. Synergism of toll-like receptor 2 (TLR2), TLR4, and TLR6 ligation on the production of tumor necrosis factor (TNF)-alpha in a spontaneous arthritis animal model of interleukin (IL)-1 receptor antagonist-deficient mice.
Jung YO; Cho ML; Lee SY; Oh HJ; Park JS; Park MK; Park MJ; Ju JH; Kim SI; Park SH; Kim HY; Min JK
Immunol Lett; 2009 Apr; 123(2):138-43. PubMed ID: 19428561
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptors 1 and 6 are involved in TLR2-mediated macrophage activation by hepatitis C virus core and NS3 proteins.
Chang S; Dolganiuc A; Szabo G
J Leukoc Biol; 2007 Sep; 82(3):479-87. PubMed ID: 17595379
[TBL] [Abstract][Full Text] [Related]
7. Role of TLR1 and TLR6 in the host defense against disseminated candidiasis.
Netea MG; van de Veerdonk F; Verschueren I; van der Meer JW; Kullberg BJ
FEMS Immunol Med Microbiol; 2008 Jan; 52(1):118-23. PubMed ID: 18036178
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor 2 (TLR2) plays a role in controlling cutaneous leishmaniasis in vivo, but does not require activation by parasite lipophosphoglycan.
Halliday A; Bates PA; Chance ML; Taylor MJ
Parasit Vectors; 2016 Oct; 9(1):532. PubMed ID: 27716391
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor 6 senses Mycobacterium avium and is required for efficient control of mycobacterial infection.
Marinho FA; de Paula RR; Mendes AC; de Almeida LA; Gomes MT; Carvalho NB; Oliveira FS; Caliari MV; Oliveira SC
Eur J Immunol; 2013 Sep; 43(9):2373-85. PubMed ID: 23716075
[TBL] [Abstract][Full Text] [Related]
10. Heterodimerization of TLR2 with TLR1 or TLR6 expands the ligand spectrum but does not lead to differential signaling.
Farhat K; Riekenberg S; Heine H; Debarry J; Lang R; Mages J; Buwitt-Beckmann U; Röschmann K; Jung G; Wiesmüller KH; Ulmer AJ
J Leukoc Biol; 2008 Mar; 83(3):692-701. PubMed ID: 18056480
[TBL] [Abstract][Full Text] [Related]
11. Local treatment with BPPcysMPEG reduces allergic airway inflammation in sensitized mice.
Knothe S; Mutschler V; Rochlitzer S; Winkler C; Ebensen T; Guzman CA; Hohlfeld J; Braun A; Muller M
Immunobiology; 2011; 216(1-2):110-7. PubMed ID: 20619481
[TBL] [Abstract][Full Text] [Related]
12. TLR1- and TLR6-independent recognition of bacterial lipopeptides.
Buwitt-Beckmann U; Heine H; Wiesmüller KH; Jung G; Brock R; Akira S; Ulmer AJ
J Biol Chem; 2006 Apr; 281(14):9049-57. PubMed ID: 16455646
[TBL] [Abstract][Full Text] [Related]
13. CD40 signaling is impaired in L. major-infected macrophages and is rescued by a p38MAPK activator establishing a host-protective memory T cell response.
Awasthi A; Mathur R; Khan A; Joshi BN; Jain N; Sawant S; Boppana R; Mitra D; Saha B
J Exp Med; 2003 Apr; 197(8):1037-43. PubMed ID: 12695487
[TBL] [Abstract][Full Text] [Related]
14. Surface-expressed TLR6 participates in the recognition of diacylated lipopeptide and peptidoglycan in human cells.
Nakao Y; Funami K; Kikkawa S; Taniguchi M; Nishiguchi M; Fukumori Y; Seya T; Matsumoto M
J Immunol; 2005 Feb; 174(3):1566-73. PubMed ID: 15661917
[TBL] [Abstract][Full Text] [Related]
15. Toll-like receptor 6-independent signaling by diacylated lipopeptides.
Buwitt-Beckmann U; Heine H; Wiesmüller KH; Jung G; Brock R; Akira S; Ulmer AJ
Eur J Immunol; 2005 Jan; 35(1):282-9. PubMed ID: 15580661
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptor 2 mediates inflammatory cytokine induction but not sensitization for liver injury by Propioni- bacterium acnes.
Romics L; Dolganiuc A; Velayudham A; Kodys K; Mandrekar P; Golenbock D; Kurt-Jones E; Szabo G
J Leukoc Biol; 2005 Dec; 78(6):1255-64. PubMed ID: 16204620
[TBL] [Abstract][Full Text] [Related]
17. TLR9 signaling is essential for the innate NK cell response in murine cutaneous leishmaniasis.
Liese J; Schleicher U; Bogdan C
Eur J Immunol; 2007 Dec; 37(12):3424-34. PubMed ID: 18034422
[TBL] [Abstract][Full Text] [Related]
18. Role for MyD88, TLR2 and TLR9 but not TLR1, TLR4 or TLR6 in experimental autoimmune encephalomyelitis.
Miranda-Hernandez S; Gerlach N; Fletcher JM; Biros E; Mack M; Körner H; Baxter AG
J Immunol; 2011 Jul; 187(2):791-804. PubMed ID: 21685327
[TBL] [Abstract][Full Text] [Related]
19. Lipopeptides are signaled by Toll-like receptor 1, 2 and 6 in endolysosomes.
Motoi Y; Shibata T; Takahashi K; Kanno A; Murakami Y; Li X; Kasahara T; Miyake K
Int Immunol; 2014 Oct; 26(10):563-73. PubMed ID: 24860120
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor 9 acts at an early stage in host defence against pneumococcal infection.
Albiger B; Dahlberg S; Sandgren A; Wartha F; Beiter K; Katsuragi H; Akira S; Normark S; Henriques-Normark B
Cell Microbiol; 2007 Mar; 9(3):633-44. PubMed ID: 17004992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
